"At ReCode, I have the rare opportunity to drive a seismic shift for genetic medicines and make a meaningful difference for patients with rare diseases."
ReCode Therapeutics
Biotechnology Research
Powering the next wave of genetic medicines through superior delivery
Our Dynamic, Science-Driven Leadership Team
Meet some of ReCode’s leaders who guide our mission to serve patients with life-limiting respiratory diseases
-
Shehnaaz Suliman, M.D. (MB ChB), M.B.A., M.Phil.
Biotech Leader. Physician. Drug Developer. Company Builder
-
David Lockhart
President & CSO, ReCode Therapeutics | Scientist | Biotechnology Executive
-
John Matthews
Chief Medical Officer at ReCode Therapeutics Pulmonologist and Drug Developer Alumni Guys and St Thomas’, Royal Brompton, Renal and Mead Ward, Lane…
-
Daniel Siegwart
Professor at UT Southwestern Medical Center
About ReCode Therapeutics: Mission & Purpose
ReCode’s mission is to develop targeted, disease-modifying genetic medicines for patients with life-limiting diseases. Powered by its proprietary lipid nanoparticle (LNP) platform, our pipeline includes lead programs for patients living with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Our treatments seek to serve underserved populations and have the potential to tremendously impact the quality and length of patients’ lives.
Learn More about ReCode Follow us on TwitterOur Technology and Platform
At ReCode, we’ve created a first-in-class, broad and customizable platform of non-viral lipid nanoparticles (LNPs), enabling us to precisely deliver our medicines safely and effectively. Our company shares a strong passion and experience with well-defined drug development and regulatory pathways, helping us rapidly advance our programs for CF and PCD. We hope to have a significant effect where there is a high-hurdle need and deliver the next generation of genetic based therapies for patients.
Go Deeper: ReCode’s Proprietary Platform & TechnologyBe a Part of Something Bigger: Join our Team
At ReCode, we bring a unique blend of rigor, creativity, and curiosity to our high-hurdle mission: harnessing our multi-platform approach to develop disease-modifying medicines. Our team is uniquely positioned to tackle this challenge, given our extensive experience in RNA delivery technologies, protein structure, tRNA biology, mRNA manufacturing, gene editing, and drug development. Join our growing team in Dallas, Texas or Menlo Park, California, and be a part of the future we’re building.
Browse Job Openings